tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DNLI Stock Latest News

Denali Therapeutics price target lowered to $32 from $70 at UBS
The FlyDenali Therapeutics price target lowered to $32 from $70 at UBS
17d ago
DNLI
Denali Therapeutics files to sell 29.29M shares of common stock for holders
PremiumThe Fly
Denali Therapeutics files to sell 29.29M shares of common stock for holders
1M ago
DNLI
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ADIL
CDXS
Denali Therapeutics price target lowered to $95 from $105 at H.C. Wainwright
PremiumThe Fly
Denali Therapeutics price target lowered to $95 from $105 at H.C. Wainwright
2M ago
DNLI
Denali Therapeutics to sell 3.24M shares at $17.07 in private placement
PremiumThe Fly
Denali Therapeutics to sell 3.24M shares at $17.07 in private placement
2M ago
DNLI
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
PremiumPress ReleasesDenali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
2M ago
DNLI
Denali Therapeutics Strengthens R&D with $500M Investment
PremiumCompany Announcements
Denali Therapeutics Strengthens R&D with $500M Investment
2M ago
8K
DNLI
Denali Therapeutics expects cash runway to extend into 2028
PremiumThe Fly
Denali Therapeutics expects cash runway to extend into 2028
2M ago
DNLI
Denali Therapeutics reports Q4 EPS (86c), consensus (80c)
PremiumThe Fly
Denali Therapeutics reports Q4 EPS (86c), consensus (80c)
2M ago
DNLI
Denali Therapeutics Announces $500 million Private Placement Equity Financing
PremiumPress Releases
Denali Therapeutics Announces $500 million Private Placement Equity Financing
2M ago
DNLI
Denali Therapeutics (DNLI) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Denali Therapeutics (DNLI) Q4 Earnings Cheat Sheet
2M ago
DNLI
Denali Therapeutics’ treatment of MPS IIIA granted FDA orphan designation
PremiumThe Fly
Denali Therapeutics’ treatment of MPS IIIA granted FDA orphan designation
2M ago
DNLI
Denali Therapeutics ALS study failue ‘clearing event,’ says B. Riley
PremiumThe FlyDenali Therapeutics ALS study failue ‘clearing event,’ says B. Riley
2M ago
SNY
DNLI
Denali continues decline after Sanofi ALS study failure
PremiumThe Fly
Denali continues decline after Sanofi ALS study failure
2M ago
SNY
DNLI
Denali Therapeutics price target lowered to $27 from $32 at Citi
PremiumThe Fly
Denali Therapeutics price target lowered to $27 from $32 at Citi
2M ago
DNLI
Denali Therapeutics’ ALS Drug Fails Phase 2, Yet MS Trial Continues
PremiumCompany Announcements
Denali Therapeutics’ ALS Drug Fails Phase 2, Yet MS Trial Continues
2M ago
8K
DNLI
Denali announces data, expansion of BBB-crossing enzyme replacement therapy
PremiumThe Fly
Denali announces data, expansion of BBB-crossing enzyme replacement therapy
3M ago
DNLI
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
PremiumPress Releases
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
3M ago
DNLI
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
PremiumPress Releases
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
3M ago
DNLI
Denali Therapeutics announces key anticipated 2024 milestones, priorities
PremiumThe FlyDenali Therapeutics announces key anticipated 2024 milestones, priorities
4M ago
DNLI
Denali Therapeutics initiated with bullish view at Citi, here’s why
PremiumThe Fly
Denali Therapeutics initiated with bullish view at Citi, here’s why
5M ago
DNLI
Denali Therapeutics initiated with bullish view at Citi
PremiumThe Fly
Denali Therapeutics initiated with bullish view at Citi
5M ago
DNLI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >